Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by Baylor1965on Dec 07, 2011 9:46am
301 Views
Post# 19298648

RE: OK People... Get your questions ready!!

RE: OK People... Get your questions ready!!

easy there Hunter...I've always respected your opinions but to be fair management has sucked bigtime in their communication since the successful placebo trial....say what you want about A.Moore but he was transparent he was always an email away and he definitely respected his fidicuiary duty of playing house with our money.

I have no problem with management not disclosing much because they want to protect their core competencies but I do have a problem when management doesn't say much because they don't have for us insignificant shareholders.

Bullboard Posts